138 related articles for article (PubMed ID: 32835668)
21. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of Shaoyao Decoction against colorectal cancer via the Keap1-Nrf2-ARE signaling pathway.
Wang X; Saud SM; Zhang X; Li W; Hua B
J Ethnopharmacol; 2019 Sep; 241():111981. PubMed ID: 31146002
[TBL] [Abstract][Full Text] [Related]
23. Ilexgenin A prevents early colonic carcinogenesis and reprogramed lipid metabolism through HIF1α/SREBP-1.
Zhang L; Qiao X; Chen M; Li P; Wen X; Sun M; Ma X; Hou Y; Yang J
Phytomedicine; 2019 Oct; 63():153011. PubMed ID: 31301538
[TBL] [Abstract][Full Text] [Related]
24. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.
Zielińska M; Ben Haddou T; Cami-Kobeci G; Sałaga M; Jarmuż A; Padysz M; Kordek R; Spetea M; Husbands SM; Fichna J
Eur J Pharmacol; 2015 Oct; 765():582-90. PubMed ID: 26404500
[TBL] [Abstract][Full Text] [Related]
26. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
27. Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer.
Mashtoub S; Chartier LC; Trinder D; Lawrance IC; Howarth GS
Nutr Cancer; 2022; 74(2):715-723. PubMed ID: 33840308
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis.
Yao J; Xie J; Xie B; Li Y; Jiang L; Sui X; Zhou X; Pan H; Han W
Biochem Pharmacol; 2016 Sep; 115():51-63. PubMed ID: 27288548
[TBL] [Abstract][Full Text] [Related]
29. Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer.
James S; Aparna JS; Babu A; Paul AM; Lankadasari MB; Athira SR; Kumar SS; Vijayan Y; Namitha NN; Mohammed S; Reshmi G; Harikumar KB
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947113
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer.
Koh SJ; Kim JM; Kim IK; Ko SH; Kim JS
J Gastroenterol Hepatol; 2014 Mar; 29(3):502-10. PubMed ID: 24716225
[TBL] [Abstract][Full Text] [Related]
31. Cilostazol and enzymatically modified isoquercitrin attenuate experimental colitis and colon cancer in mice by inhibiting cell proliferation and inflammation.
Kangawa Y; Yoshida T; Maruyama K; Okamoto M; Kihara T; Nakamura M; Ochiai M; Hippo Y; Hayashi SM; Shibutani M
Food Chem Toxicol; 2017 Feb; 100():103-114. PubMed ID: 27989839
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model.
Girardi B; Principi M; Pricci M; Giorgio F; Iannone A; Losurdo G; Ierardi E; Di Leo A; Barone M
Carcinogenesis; 2018 Oct; 39(10):1274-1282. PubMed ID: 30084990
[TBL] [Abstract][Full Text] [Related]
33. Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.
Zheng L; Zhang YL; Dai YC; Chen X; Chen DL; Dai YT; Tang ZP
World J Gastroenterol; 2017 Feb; 23(7):1180-1188. PubMed ID: 28275298
[TBL] [Abstract][Full Text] [Related]
34. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
Xu H; Li J; Chen H; Ghishan FK
Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2.
Elimrani I; Koenekoop J; Dionne S; Marcil V; Delvin E; Levy E; Seidman EG
Nutr Cancer; 2017; 69(2):276-288. PubMed ID: 28045548
[TBL] [Abstract][Full Text] [Related]
36. Intervention with
Li S; Fu C; Zhao Y; He J
Biomed Res Int; 2019; 2019():8020785. PubMed ID: 31317039
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
38. 2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice.
Li H; Wu WK; Li ZJ; Chan KM; Wong CC; Ye CG; Yu L; Sung JJ; Cho CH; Wang M
Br J Pharmacol; 2010 Jul; 160(6):1352-61. PubMed ID: 20590626
[TBL] [Abstract][Full Text] [Related]
39. Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth.
Li D; Zhang Y; Liu K; Zhao Y; Xu B; Xu L; Tan L; Tian Y; Li C; Zhang W; Cao H; Zhan YY; Hu T
Lab Invest; 2017 Nov; 97(11):1343-1353. PubMed ID: 28759012
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Mashtoub S
Scand J Gastroenterol; 2020 Jan; 55(1):47-54. PubMed ID: 31825688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
